1. Home
  2. MPC vs MRNA Comparison

MPC vs MRNA Comparison

Compare MPC & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Petroleum Corporation

MPC

Marathon Petroleum Corporation

N/A

Current Price

$411.60

Market Cap

106.9B

Sector

Energy

ML Signal

N/A

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$223.85

Market Cap

91.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MPC
MRNA
Founded
1887
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.9B
91.2B
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
MPC
MRNA
Price
$411.60
$223.85
Analyst Decision
Buy
Hold
Analyst Count
18
23
Target Price
★ $461.94
$158.47
AVG Volume (30 Days)
2.2M
★ 13.6M
Earning Date
11-03-2026
11-06-2026
Dividend Yield
★ 1.07%
N/A
EPS Growth
★ 31.15
21.77
EPS
★ 45.40
N/A
Revenue
N/A
★ $19,263,000,000.00
Revenue This Year
$36.26
$24.04
Revenue Next Year
N/A
$10.63
P/E Ratio
$9.10
★ N/A
Revenue Growth
N/A
★ 4.29
52 Week Low
$161.93
$22.28
52 Week High
$493.98
$280.80

Technical Indicators

Market Signals
Indicator
MPC
MRNA
Relative Strength Index (RSI) 46.78 49.65
Support Level $364.73 $181.02
Resistance Level $431.08 $254.48
Average True Range (ATR) 20.29 18.70
MACD -3.47 -2.26
Stochastic Oscillator 43.45 43.04

Price Performance

Historical Comparison
MPC
MRNA

About MPC Marathon Petroleum Corporation

Marathon Petroleum is a leading integrated downstream and midstream energy company that operates 13 refineries in the Gulf Coast, midcontinent, and West Coast regions of the United States with an aggregate crude oil refining capacity of 3.0 million barrels per day. The company is one of the largest producers of renewable diesel in the US; its Dickinson, North Dakota, facility has the capacity to produce 184 million gallons per year, and its Martinez, California, joint venture facility (a 50/50 partnership with Neste) reached its full capacity of 730 million gallons per year in late 2024. Marathon also owns the general partner and approximately 64% of MPLX LP, a large-cap master limited partnership that owns and operates midstream energy infrastructure and logistics assets.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: